Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo

Lori Gawron · with Planned Parenthood Association of Utah · NCT06162611

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–35 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
790
US sites recruiting
1
Study start
November 6, 2023
Record last updated
June 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Intrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This proposal will identify the most effective way to start an implant for emergency contraception using a randomized controlled trial comparing pregnancy risk between those receiving the implant vs. the implant plus oral emergency contraception (EC). Data from this project will inform clinical practice and add another option, the implant, for those desiring a long acting, highly effective contraceptive method when they present for emergency contraception.

Being studied: Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg; Etonogestrel implant with oral placebo

Conditions: Emergency Contraception

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Between 18-35 years old
  • Unprotected intercourse within 72 hours
  • Biologically capable of pregnancy (intact uterus without prior sterilization surgery
  • Fluent in English and/or Spanish
  • Have a regular menstrual cycle (21-35 days)
  • Known last menstrual period (+/- 3 days)
  • Working (cell) phone number
  • Willing to comply with the study requirements
  • Willing to abstain from any CYP3A4 inducer for 5 days

Exclusion Criteria

  • Current pregnancy (+urine pregnancy test in clinic)
  • Breastfeeding
  • Contraindication to ENG or LNG based on CDC MEC/SPR
  • Sterilization, hysterectomy, or has an IUD or contraceptive implant in place
  • Vaginal bleeding of unknown etiology
  • Previous use of EC in same cycle
  • Allergy to LNG or ENG
  • History of intolerance/ side effects with ENG Implant
  • Current (past 7 days) use of any CYP3A4 inducer
  • Plan to use any other steroid hormone in the next 4 weeks (testosterone, estrogen, progesterone)
  • Ended a pregnancy at or under 20 weeks gestational age within last 2 weeks
  • Ended a pregnancy over 20 weeks gestational age in last 6 weeks
  • Use of any injectable hormonal contraceptive (Depo-Provera) in the last 15 weeks
  • Use of any oral EC, contraceptive pills, patches, vaginal rings, or an IUD or Implant in the last 2 weeks

Recruiting US locations

  • Planned Parenthood Association of Utah

    Salt Lake City, UT 84102

    Site contact: Corinne Sexsmith

Study contacts (from the official record)

  • Corinne Sexsmith, MPH · 801-213-2419 · corinne.sexsmith@hsc.utah.edu
  • Sarah Elliott, MPH · 801-646-7066 · sarah.elliott@hsc.utah.edu
All women’s health studies in Utah →
Etonogestrel (ENG) Implant Insertion for Emergency Contraception… (NCT06162611) | Bored Studies